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Abstract 
Bone marrow mesenchymal stem cells (BMSC) can differentiate into diverse cell types, 
including adipogenic, osteogenic, chondrogenic and myogenic lineages. There are lots of 
BMSC accumulated in atherosclerosis vessels and differentiate into VSMC. However, it is 
unclear whether VSMC originated from BMSC (BMSC-SMC) could remodel the vessel in 
new tunica intima or promote the pathogenesis of atherosclerosis. In this study, BMSC 
were differentiated into VSMC in response to the transforming growth factor β (TGF-β) 
and  shown  to  express  a  number  of  VSMC  markers,  such  as  α-smooth  muscle  actin 
(α-SMA)  and  smooth  muscle  myosin  heavy  chain1  (SM-MHC1). BMSC-SMC  became 
foam cells after treatment with 80 mg/L ox-LDL for 72 hours. Ox-LDL could upregulate 
scavenger  receptor  class  A  (SR-A)  but  downregulate  the  ATP-binding  cassette  trans-
porter A1 (ABCA1) and caveolin-1 protein expression, suggesting that modulating rela-
tive protein activity contributes to smooth muscle foam cell formation in BMSC-SMC. 
Furthermore, we found that BMSC-SMC have some biological characteristics that are 
similar to VSMC, such as the ability of proliferation and secretion of extracellular matrix, 
but, at the same time, retain some biological characteristics of BMSC, such as a high level 
of migration. These results suggest that BMSC-SMC could be induced to foam cells and 
be involved in the development of atherosclerosis. 
Key words: Bone marrow mesenchymal stem cells; vascular smooth muscle cells; atherosclerosis; 
SR-A; ABCA1; caveolin-1 
Introduction 
Atherosclerotic  cardiovascular  disease  such  as 
coronary  atherosclerosis  and  stroke  remains  the 
leading cause of death all over the world [1, 2]. Vari-
ous cell types play crucial roles in the destabilization 
and subsequent rupture or erosion of an atheroscle-
rotic  plaque,  including  apoptosis  of  foam  cells  and 
proliferation of vascular smooth muscle cells (VSMC) 
at different phases of the disease [3]. Cholesterol ac-
cumulation in vascular smooth muscle cells (VSMC) 
and monocytes/macrophages leads to the formation 
of lipid-loaded cells, causing a key process of athero-
sclerosis. It is considered that macrophages taking up 
ox-LDL could modify the production of cytokines and 
other  factors  through  oxidative-sensitive  signaling 
pathways, and then initiate and promote atheroscle-
rosis. 
Numerous studies have reported that excessive 
accumulation of vascular smooth muscle cells (VSMC) 
has a key role in the pathogenesis of vascular diseases. 
It  has  been  assumed  that  VSMC  derived  from  the 
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outer medial layer migrate, proliferate, and synthesize 
extracellular matrix components on the luminal side 
of the vessel and thereby leading to neointimal hy-
perplasia [4, 5]. Bone marrow mesenchymal stem cells 
(BMSC) have a self-renewal capacity, long-term via-
bility, and the potential to differentiate into diverse 
cell types, such as adipogenic, osteogenic, chondro-
genic,  and  myogenic  lineages  [6-8].  In  vitro,  BMSC 
have  been  shown  to  differentiate  into  VSMC  in  re-
sponse to the transforming growth factor β (TGF-β) 
[9],  mechanical  stress  [10],  and  direct  contact  with 
vascular endothelial cells [11].  Neointimal SMC  has 
been  shown  to  express  a  number  of  hematopoietic 
lineage markers [12, 13]. Sata and colleagues showed 
that bone marrow is the potential source of vascular 
progenitors  that  contribute  to  pathological  arterial 
remodeling in models of postangioplasty, restenosis, 
transplant-associated  arteriosclerosis,  and  hyper-
lipidemia-induced atherosclerosis [2]. 
Moreover, intimal SMC in graft arterial disease 
can originate from recipient bone marrow cells [14]. 
On  the  other  hand,  there  have  been  few  studies 
closely  following  the  cell  differentiation  of  smooth 
muscle  lineage  among  BMSC.  Reports  have  shown 
that BMSC differentiate not only into cardiomyocytes, 
but also into vascular smooth muscle cells progenitors 
and endothelial cells. These cell types are involved in 
the development of vascular systems, including an-
giogenic sprouting and vessel enlargement. However, 
the biological characteristics of foam cell formation in 
BMSC-SMC  involved  in  atherosclerosis  are  largely 
unknown. 
Here  we  show  that  BMSC  yield  VSMC 
(BMSC-SMC), which exhibit distinct characteristics by 
treatment with oxidative modified low-density lipo-
protein (ox-LDL), can be induced to foam cells and be 
involved in the development of atherosclerosis.  
Results  
VSMC differentiated from bone marrow MSC 
TGF-β signaling is thought to direct, in part, the 
differentiation of mesenchymal lineage cell types to 
VSMC [15]. Treating of BMSC with 2.5 ng/ml β-FGF 
and 5 ng/ml TGF-β for 15 days elicited their differen-
tiation into VSMC, as demonstrated by their increased 
expression  of  the  SMC-specific  cytoskeletal  protein 
α-SMA  and  the  SMC-specific  contractile  protein, 
SM-MHC1 (Figure 1). 
Foam cell formation of BMSC-SMC and VSMC in-
duced by ox-LDL  
Ox-LDL is involved in the pathogenesis of ath-
erosclerosis. Foam cells, one of the hallmarks of ath-
erosclerotic plaques, develop when monocyte-derived 
macrophages or smooth muscle cells within the arte-
rial  wall  take  up  ox-LDL  via  scavenger  receptors. 
Using Oil Red O staining, we checked the morpho-
logical change of cells after incubation of BMSC-SMC 
and VSMC with 80 mg/L ox-LDL for 72 hours, and 
we  found  that  lipid  staining  became  positive  com-
pared with the control group (Figure 2, Table 1). There 
was much more cholesterol assembled in BMSC-SMC 
compared with VSMC. 
 
Table 1 Intracellular lipid content in BMSC-SMC and 
VSMC. Cells were treated with the 80mg/L ox-LDL for 72 
hours. Cellular lipid was extracted, and free cholester-
ol(FC), total cholesterol(TC) were analyzed by HPLC. CE 
and ratio of CE/TC were calculated. 
Cells group  FC(µg/m
g protein) 
CE(µg/m
g protein) 
TC(µg/m
g protein) 
CE/TC(
%) 
Control  45.9±3.2  5.3±2.6  40.1±3.5  13.2 
VSMC+ox-LDL  86.5±4.1*  116.6±4.5*   196.7±9.5*   59.3 
BMSC-SMC+ox-LDL  92.1±9.4   167.6±8.9   301.3±8.5   55.6 
*P<0.05 vs Control  
 
Effect of ox-LDL on cell proliferation in 
BMSC-SMC and VSMC  
The  growth  curve  of  BMSC-SMC  and  VSMC 
represented an “S” shape. Also, the doubling times 
were 32 hours and 20 hours respectively. After treat-
ment with 80 mg/L ox-LDL, the doubling times were 
28 hours and 15 hours respectively (Figure 3A).  
To investigate whether the ox-LDL treatment has 
an effect on cell cycle regulation, we assessed for cell 
cycle  distribution  by  flow  cytometry.  As  shown  in 
Figure 3B, cells cultured for 3 days in the presence of 
ox-LDL resulted in an accumulation of these cells in 
the G0/G1 phase of the cell cycle, with a concomitant 
decrease in the proportion of those in S and G2/M 
phases. But there is no statistical significance in the 
cases of BMSC-SMC and VSMC. 
Effects of ox-LDL on cell collagen synthesis, at-
tachment, and migration in BMSC-SMC and VSMC  
To  determine  if  the  protein  level  of  the  main 
component  of  extracellular  matrix,  i.e.,  collagen,  is 
altered by ox-LDL, total collagen content was deter-
mined in BMSC-SMC and VSMC using hydroxypro-
line  assay.  As  shown  in  Figure  4A,  ox-LDL  signifi-
cantly  reduced  collagen  production  compared  with 
the  control  group,  but  there  is  no  statistical  signifi-
cance for BMSC-SMC and VSMC. Int. J. Biol. Sci. 2011, 7 
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To  determine  whether  cell  attachment  was  af-
fected by ox-LDL, cells were seeded and allowed to 
attach on glass plates for time periods up to 1 hour. 
Incubation with ox-LDL slightly increased attachment 
of BMSC-SMC compared with control cells. But there 
is no statistical significance compared with the control 
group.  However,  incubation  with  ox-LDL  slightly 
decreased attachment of VSMC compared with con-
trol group but there is no statistical significance (Fig-
ure 4B). 
Migration of VSMC within the arterial wall is a 
crucial  event  in  the  remodeling  and  progression  of 
atherosclerotic plaques as well as in vascular repair 
[16].  To  determine  whether  ox-LDL  can  affect 
BMSC-SMC and VSMC migration, cells were treated 
with 80 mg/L ox-LDL for 24 hours. The result sug-
gests  that  ox-LDL  are  effective  in  accelerating 
BMSC-SMC and VSMC migration compared with the 
control  group  (P<0.01).  There  was  much  more 
BMSC-SMC  migration  compared  with  VSMC  after 
treatment with ox-LDL (Figure 4C). 
 
 
 
 
Figure 1. Phenotypic characterization of BMSC, BMSC-SMC and VSMC. Immunofluorescence analysis of α-SMA and SM-MHC1 
in BMSC, BMSC-SMC and VSMC (100×). (A) The expression of α-SMA in BMSC (a), VSMC (b) and BMSC-SMC (c); the expression 
of SM-MHC1 in BMSC (d), VSMC (e) and BMSC-SMC (f). (B) RT-PCR analyzed the expression of α-SMC and SM-MHC1 in VSMC 
(line 1), BMSC-SMC (line 2) and BSMC (line 3). Int. J. Biol. Sci. 2011, 7 
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Figure 2. Ox-LDL induced foam cell formation of BMSC, VSMC, BMSC-SMC and macrophages by Oil Red O staining. BMSC, 
VSMC, BMSC-SMC and macrophases were incubated with 80 mg/L ox-LDL (e, f, g and h) and PBS (a, b, c and d) for 72 hours. 
The cells were harvested or fixed for Oil Red O staining. 
 
 
 
 
 
Figure 3. Effect of ox-LDL on cell proliferation in BMSC-SMC and VSMC. (A) Cell growth curves of BMSC-SMC and VSMC after 
treatment with 80 mg/L ox-LDL for 24, 48, 72 and 96 h. (B) Cell cycle distribution in VSMC (b) and BMSC-SMC (d) after 
treated with 80 mg/L ox-LDL and PBS (a and c) for 72 hours. Int. J. Biol. Sci. 2011, 7 
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Figure 4. Effects of ox-LDL on cell collagen synthesis, attachment and migration in BMSC-SMC and VSMC. (A) Cell collagen 
synthesis was determined by hydroxyproline-based assays. BMSC-SMC and VSMC were treated with 80 mg/L ox-LDL for 72 
hours. (B) Cell attachment was analyzed by cell adhesion assays. VSMC (b) and BMSC-SMC (d) were treated with 80 mg/L 
ox-LDL and PBS (a and c) for 1 hour. (C) Cell migration was detected by wound healing assays. BMSC-SMC and VSMC were 
treated with 80 mg/L ox-LDL or without 80 mg/L ox-LDL for 0 hour (a: BMSC-SMC + ox-LDL and c: BMSC-SMC; e: VSMC + 
ox-LDL and g: VSMC) and 24 hours (b: BMSC-SMC+ox-LDL and d: BMSC-SMC; f: VSMC + ox-LDL and h: VSMC). The results were 
obtained from at least three independent measurements. *p < 0.05, **p < 0.01 compared to control. 
 
 
Effects of ox-LDL on scavenger receptor class A, 
the ATP-binding cassette transporter A1 and 
caveolin-1 expression in BMSC-SMC and VSMC  
It is postulated that ox-LDL is the ligand for the 
scavenger receptor on the membrane of macrophages 
and smooth muscle cells. LDL uptake via this path-
way leads to massive accumulation of lipid and thus 
foam cell formation. The scavenger receptor activity is 
up  regulated  in  the  smooth  muscle  cells  of  athero-
sclerotic  lesions.  In  this  study,  incubation  with  the 
80mg/L ox-LDL for 72 hours significantly up regu-
lated  the  scavenger  receptor  class  A  (SR-A)  protein 
expression of BMSC-SMC and VSMC compared to the 
control group, respectively. There was a lot more in-
creased scavenger receptor class A (SR-A) protein in 
BMSC-SMC compared with VSMC (Figure 5A).  
The  ATP-binding  cassette  transporter  A1 
(ABCA1) exports excess cellular cholesterol into the 
HDL pathway and reduces cholesterol accumulation 
in macrophages. We examined the protein level of the 
ATP-binding  cassette  transporter  A1  (ABCA1)  in 
BMSC-SMC and VSMC by western blotting analysis 
to  study  whether  the  ATP-binding  cassette  trans-
porter  A1  (ABCA1)  is  involved  in  cholesterol  accu-
mulation  in  BMSC-SMC  and  if  it  is  regulated  by 
ox-LDL.  The  result  demonstrated  that  the 
ATP-binding cassette transporter A1 (ABCA1) protein 
level  was  high  in  untreated  BMSC-SMC  compared 
with untreated VSMC, and the 80 mg/L ox-LDL sig-Int. J. Biol. Sci. 2011, 7 
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nificantly  decreased  ABCA1  protein  level  in  both 
BMSC-SMC and VSMC (Figure 5B). 
Caveolins, and especially caveolin-1, have been 
implicated  in  the  regulation  of  cellular  cholesterol 
metabolism and lipid uptake, as well as their efflux 
[17]. We examined the protein level of caveolin-1 in 
BMSC-SMC and VSMC by western blotting analysis 
to determine whether caveolin-1 is involved in lipid 
uptake in BMSC-SMC and if it is regulated by ox-LDL. 
The result demonstrated that caveolin-1 protein level 
was  high  in  untreated  BMSC-SMC  compared  with 
untreated VSMC. After treatment with the 80 mg/L 
ox-LDL for 72 hours, the expression of caveolin-1 was 
significantly  decreased  in  both  BMSC-SMC  and 
VSMC (Figure 5C). 
 
 
Figure 5. Effects of ox-LDL on the expression of SR-A, ABCA1 and caveolin-1 in BMSC-SMC and VSMC. BMSC-SMC and VSMC 
were treated with 80 mg/L ox-LDL for 72 hours. (A) the expression of SR-A; (B) the expression of ABCA1 and (C) the ex-
pression of caveolin-1. The results were obtained from at least three independent measurements. **p < 0.01 compared to 
control. 
 
Discussion 
The process of atherosclerosis, in the beginning, 
is characterized by intimal thickening caused by hy-
perplasia of the VSMC. Recently, it has been shown 
that  vascular  progenitor  cells  exist  inside  normal 
vessel walls and the number is increased in athero-
sclerotic lesions [18]. The origin of such VSMC pro-
genitor cells is under debate, i.e., whether these cells 
are  derived  from  bone  marrow  or  dedifferentiated Int. J. Biol. Sci. 2011, 7 
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intimal cells. This indicates, however, that there may 
be many possible origins of VSMC [19-21]. It was re-
ported that blood cells contain progenitors that have 
the  potential  to  differentiate  into  either  endothelial 
cells or VSMC in vitro according to the composition of 
the culture medium [22]. BMSC are a multipotent cell 
type  that  can  differentiate  down  the  osteoblastic, 
chondrogenic,  myogenic,  or  adipogenic  lineages. 
Moreover, intimal VSMC in graft arterial disease can 
originate  from  recipient  bone  marrow  cells  [14].  In 
this study, we observed that BMSC could be induced 
into VSMC. The biology characteristics of BMSC-SMC 
are similar with VSMC. They also can express α-SMA 
and  SM-MHC1,  which  act  as  molecular  markers  in 
VSMC. These cells might take part in the development 
of atherosclerosis.  
Massive accumulation of lipid in cells leads to 
the formation of foam cells, a pathological feature of 
atherosclerosis [23, 24]. Scavenger receptors, a family 
of trimeric membrane glycoproteins at the surface of 
vascular cells, can specifically mediate the uptake of 
ox-LDL  [25].  In  normal  VSMC,  the  expression  of 
scavenger  receptors  is  weak.  However,  in  the  pres-
ence  of  appropriate  stimulation,  expression  of  the 
receptor  is  increased.  In  contrast,  expression  of  the 
receptor in smooth muscle cells of the aortic media 
did not change. These results clearly demonstrate the 
induction of scavenger receptor expression in smooth 
muscle cells of the neointima, which is the location of 
primordial  lesions  of  atherosclerosis.  Our  findings 
demonstrated  that  the  ox-LDL  significantly 
up-regulated scavenger receptor class A (SR-A) pro-
tein expression in BMSC-SMC and VSMC compared 
to untreated cells. Interestingly, a greater rate of in-
crease was found in the BMSC-SMC compared to the 
VSMC.  The  result  suggested  that  the  BMSC-SMC 
might be induced into foam cells by the up regulation 
of the SR-A protein expression. 
The  ATP-binding  cassette  transporter  A1 
(ABCA1) is a transporter that mediates the export of 
cellular cholesterol, phospholipids, and other metab-
olites to lipid-poor HDL apolipoproteins. Reciprocal 
bone marrow transplantation studies using wild type 
and  ABCA1-null  mice  have  shown  that  selectively 
over  or  under  expressing  the  ATP-binding  cassette 
transporter A1 in macrophages decreases or increases 
atherosclerosis, respectively [26]. Some studies show 
that the ATP-binding cassette transporter A1 is a car-
dioprotective  factor  and  the  reduction  of  the 
ATP-binding cassette transporter A1 activity contrib-
utes to smooth muscle foam cell formation in the in-
tima [27]. 
The potential role of caveolins in the intracellular 
transport  of  cholesterol  and  its  physical  association 
with  the  cholesterol-rich  rafts  makes  it  tempting  to 
speculate that these proteins play an important role in 
cholesterol metabolism of macrophages. The recently 
generated caveolin-1 knockout mice, confirm the im-
portance of caveolin-1 for the formation of morpho-
logically distinct caveolae [28, 29]. Caveolin-1 is also 
involved  in  the  maintenance  of  cellular  cholesterol 
homeostasis  and  lipid  transport.  Some  studies 
demonstrate that caveolae and caveolin-1 expression 
is associated with enhancement of cholesterol efflux 
[30,  31].  Our  present  study  demonstrated  that  the 
ox-LDL decreased the expressions of the ATP-binding 
cassette transporter A1 and caveolin-1. These results 
suggested  that  BMSC-SMC  might  be  induced  into 
foam cells also by down-regulation the ATP-binding 
cassette  transporter  A1  and  caveolin-1  protein  ex-
pression. Further research will help clarify the inter-
action between Caveolin-1 and the ATP-binding cas-
sette transporter A1 in BMSC-SMC. 
VSMC  proliferation  and  migration,  as  well  as, 
extracellular matrix remodeling are important events 
in  the  pathophysiological  course  of  atherosclerosis. 
These events are mediated by various cytokines and 
growth factors and also depend on the degradation of 
extracellular  matrix  by  proteinases  such  as  matrix 
metalloproteinases.  VSMC  migrate  from  the  medial 
layer of arterial wall into the intimal space and then 
form  the  neointema  progressively;  in  addition,  to-
gether  with  abundant  level  of  extracellular  matrix 
proteins, VSMC trigger the formation of atheroscle-
rotic plaques. In our previous studies we found that 
the ox-LDL promoted cell proliferation and acceler-
ated  cell  migration  in  both  BMSC-SMC  and  VSMC 
[32]; however, the extent of change was more signifi-
cant in the BMSC-SMC. These results indicated that 
BMSC-SMC could proliferate and play a role in ath-
erosclerosis.  Our  findings  provide  the  basis  for  the 
development of new therapeutic strategies for vascu-
lar diseases, by targeting mobilization, homing, dif-
ferentiation and proliferation of bone marrow-derived 
vascular progenitor cells. 
In  summary,  our  findings  indicated  that  bone 
marrow-derived  smooth  muscle  progenitor  cells 
might  become  new  targets  to  prevent  vascular  dis-
eases. We observed that BMSC could differentiate into 
VSMC and the BMSC-SMC could express α-SMA and 
SM-MHC1, which act as molecular markers in VSMC. 
Moreover,  these  BMSC-SMC  could  be  induced  into 
foam cells by ox-LDL. Some biological characteristics, 
such as foam cell formation, proliferation, migration 
and  collagens  synthesis,  are  similar  between 
BMSC-SMC and VSMC, however, the extent of these 
characteristics  change  are  more  significant  in  the Int. J. Biol. Sci. 2011, 7 
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BMSC-SMC. It may act as an important factor in the 
pathophysiological course of atherosclerosis.  
Materials and Methods 
Isolation and culture of bone marrow MSC 
Six-week-old male SD rats were obtained from 
the central animal facility of Nanhua University and 
were  euthanized  with  an  overdose  of  pentobarbital 
solution. Both tibias and femurs were dissected and 
the bone marrow was extruded in 5 mL of DMEM 
with a syringe. The cells were then plated in DMEM 
supplemented with 10% FBS and incubated at 37°C in 
a  humidified  atmosphere  containing  5%  CO2.  Non-
adherent cells were removed by replacing the medi-
um. The medium was changed every 3 days.  
Isolation and culture of VSMC 
Rat  aortic  VSMC  were  isolated  from  thoracic 
aorta of six-week-old male SD rats using the explants 
technique [33]. Briefly, after the removal of endothe-
lium and adventitia, the aortic explants were cultured 
in DMEM containing 10% FBS. After 2 weeks, cells 
that migrated out of the explants were removed by 
trypsinization and were subcultured successively. The 
identity  and  purity  of  the  VSMC  were  verified  by 
immunostaining using antibody against α-SMA. 
RT-PCR  
Expression of rat α-SMA and SM-MHC1 mRNA 
was  analyzed  by  the  RT-PCR  method.  Primers  for 
α-SMA  were  5’-ACCCAGATTATGTTTGAGACC-3’ 
(sense), 5’-CCGTCAGGCAGTTCGTAG-3’ (antisense); 
primers  for  SM-MHC1  were  5’-CGGCAACTCGT 
GTCCAAC-3’  (sense),  5’-TGCTTTCGCTCGTCTTCC 
-3’  (antisense);  primers  for β -actin  were 
5’-GCCAACCGTGAGAAGATGAC-3’  (sense), 
5’-CTGTGTTGGCATAGAGGTC-3’  (antisense).  The 
annealing  temperatures  were  55°C  for  α-SMA  and 
SM-MHC1. The numbers of cycles of PCR were 35 for 
α-SMA and SM-MHC1. β-actin was used as internal 
controls.  
Immunofluorescence  
Cells were plated on glass coverslips. After the 
treatment, the cells were washed with PBS. Then, cells 
were fixed with 4% paraformaldehyde for 10 min. All 
fixed cells were permeabilised in 0.1% Triton X-100 
for 10 min. The cells were incubated with α-SMA or 
SM-MHC1 antibody for 60 min at room temperature. 
Then  the  cells  were  incubated  with  the  secondary 
antibody,  rhodamine-conjugated  anti-rabbit  IgG 
(Amersham Life Sciences) for 30 min. Coverslips were 
mounted and analyzed by fluorescent microscopy. 
LDL isolation and oxidization  
LDL was separated from freshly normal human 
plasma by sequential ultracentrifugation, as described 
previously [34]. In brief, the obtained LDL were ex-
tensively  dialyzed  at  4°C  against  0.15  mol/L  NaCl 
and 0.01% EDTA (pH 8.0) and quantified by Bradford 
kit (Bio-Rad, Hercules, CA). After the EDTA was re-
moved, LDL was oxidized by exposure to 5 mmol/L 
CuSO4 for 24 hours at 37°C. Then the Cu2+ was re-
moved by extensive dialysis.  
Foam cell formation 
BMSC-SMC or VSMC were cultured in DMEM 
with 10% FBS for 24 hours and treated with or with-
out the 80 mg/L ox-LDL for an additional 72 hours. 
The cells were harvested or fixed for Oil Red O stain-
ing or for HPLC. 
Lipid analysis by HPLC  
Cellular lipid (TC, FC and cholesterol ester [CE]) 
contents  were  analyzed  by  our  method  described 
previously [35]. Briefly, cells were washed by PBS in 3 
times  and  lysated  by  0.1N  NaOH  solution  and  ho-
mogenized on ice for 10 seconds by ultrasound. Pro-
teins concentration was measured by using of BCA 
kit. Then an equal volume of trichloroacetic acid was 
added and centrifuged at 800g for 10 min. Use Stig-
masterol  to  do  standard  curve  first  and  repeat  the 
extraction  procedure.  The  organic  phase  was  trans-
ferred to clear glass tubes, and dried a vacuum. The 
samples  were  dissolved  in  100  µl  isopropa-
nol–acetonitrile  (v/v,  20:80),  followed  by  an  ultra-
sound water bath at room temperature for 5 minutes. 
Finally, the samples were subjected to HPLC analysis 
(Agilent 1100, Agilent Technology, USA), Cholesterol 
was  eluted  with  isopropanol-acetonitrile  solution 
(v/v, 20:80) at the speed of 1ml/minute, C-18 column; 
4℃ and detected by 206 nm UV absorption. 
Cell growth experiments 
Cells were harvested from 24 well plates by cen-
trifugation at 1000 rpm for 5 min. Each pellet was re-
suspended in 1:1 mixture of 2% trypan blue dye and 
PBS. Cells were loaded onto the hemocytometer and 
counted. The mean and standard deviation were cal-
culated for each time point. On days 1, 2 and 3 after 
the  addition  of  treatment  medium,  cells  were  tryp-
sinized  and  counted  using  a  hemocytometer.  All 
counts were obtained in duplicate at each time point.  
DNA cell cycle analysis by flow cytometry 
After  treatment  of  cells  with  the  80  mg/L 
ox-LDL for 72 hours, floated cells were discarded by 
aspiration and the attached cells were trypsinized and Int. J. Biol. Sci. 2011, 7 
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fixed with ice-cold 70% ethanol for 1 hour. The cells 
were resuspended in 1 ml RNase (1 mg/ml) for 30 
min, centrifuged and resuspended in 0.5 ml propid-
ium iodide (PI, 50 μg/ml) for 30 min at room temper-
ature. The flow cytometric analysis was performed on 
a BD flow cytometer. 
Collagen synthesis 
To test the total collagen production, cells were 
seeded in six well culture plates and grown until con-
fluent in DMEM with 10% FBS. Cells were starved for 
24 hours before the addition of the ox-LDL. After 72 
hours  of  treatment,  cells  were  scraped  on  the  cell 
culture medium of six well culture plates. Both the cell 
lysate and culture medium were removed and placed 
in test tubes, and net collagen production was deter-
mined  with  a  hydroxyproline-based  assay  as  de-
scribed previously [36].  
Cell attachment assay 
Six well culture plates were coated with fibron-
ectin  for  24  hours  at  4°C.  For  all  assays,  cells  were 
seeded at a density of 1.0×105/ml into six well culture 
plates with and without the 80 mg/L ox-LDL. After 1 
hour, the non-adherent cells were removed by wash-
ing with PBS and attached cells were fixed with 4% 
paraformaldehyde.  Attachment  was  assessed  by 
counting  the  number  of  cells  in  five  independent 
high-power fields at 100× magnification. 
Cell migration assay 
BMSC-SMC and VSMC were seeded at a density 
of 1.0×105/ml into six well culture plates and incu-
bated at 37°C for 48 hours. A cotton swab was used to 
wound the monolayer and denude two areas in each 
well of cells. Then cells were treated with and without 
the  80  mg/L  ox-LDL  for  24  hours.  Migration  was 
evaluated by quantitating migration of cells into the 
denuded areas of the cultures. Results are reported as 
means ± SE of five different fields, from three exper-
iments, counted at 200× magnification. 
Western blot analysis 
Following specified treatments, BMSC-SMC and 
VSMC  were  washed  twice  with  ice-cold  PBS  and 
harvested  in  sample  buffer.  Soluble  extracts  were 
prepared  by  centrifugation  at  12000g  for  30  min  at 
4°C. Protein concentration was determined using the 
BCA kit (Pierce Chemical Co, Rockford, IL). Equiva-
lent amounts of protein (40 μg) for each sample were 
resolved in SDS-PAGE. After electrophoresis, proteins 
were transferred to nitrocellulose membranes. Mem-
branes were incubated in TBST containing 5% nonfat 
milk for 1 hour at room temperature. The blots were 
then reacted with primary antibody overnight at 4°C. 
Antibodies  used  for  western  blot  analysis  included 
caveolin-1,  scavenger  receptor  class  A,  the 
ATP-binding cassette transporter A1, and β-actin an-
tibody (Sigma). After washing with TBST, the mem-
brane  was  then  incubated  with  the  corresponding 
horseradish  peroxidase  conjugated  secondary  anti-
bodies (Cell signaling). The signals were visualized by 
ECL (Pierce Chemical Co.) and then exposed to X-ray 
films.  
Statistical Analysis 
Data are expressed as mean ± SEM. The statisti-
cal  significance  of  differences  was  assessed  by  Stu-
dent’s t tests or ANOVA, as appropriate; a value of 
P<0.05 was considered statistically significant. 
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